Page 44 - Mathematical Techniques of Fractional Order Systems
P. 44

34  Mathematical Techniques of Fractional Order Systems


            ACKNOWLEDGMENTS
            This work was supported by FCT, through IDMEC, under LAETA, projects UID/EMS/
            50022/2013, BoneSys, and IF/00653/2012.

            REFERENCES
            Ayati, B.P., Edwards, C.M., Webb, G.F., Wikswo, J.P., 2010. A mathematical model of bone
               remodeling dynamics for normal bone cell populations and myeloma bone disease. Biol.
               Direct 5 (1), 28.
            Azar, A.T., Vaidyanathan, S., Ouannas, A. (Eds.), 2017. Fractional Order Control and
               Synchronization of Chaotic Systems. Springer, New York.
            Belinha, J., Dinis, L.M.J.S., Natal Jorge, R.M., 2015. The meshless methods in the bone tissue
               remodelling analysis. Procedia Eng. 110, 51 58.
            Bellido, T., Plotkin, L.I., Bruzzaniti, A., 2014. Chapter 2 - Bone Cells. Basic and Applied Bone
               Biology. Academic Press, San Diego, pp. 27 45, chapter 2.
            Bonucci, E., Ballanti, P., 2014. Osteoporosis — bone remodeling and animal models. Toxicol.
               Pathol. 42, 957 969.
            Boyce, B.F., 2012. Bone biology ad pathology. In: Coleman, R., Abrahamsson, P.-A., Hadji, P.
               (Eds.), Handbook of Cancer-Related Bone Disease, second ed. BioScientifica, pp. 5 6.
            Capacete, J.D.C., 2016. Biochemical and Biomechanic Integrated Modeling ofBone, Master the-
               sis, Instituto Superior Te ´cnico.
            Casimiro, S., Guise, T.A., Chirgwin, J., 2009. The critical role of the bone microenvironment in
               cancer metastases. Mol. Cell. Endocrinol. 310 (1-2), 71 81.
            Casimiro, S., Ferreira, A.R., Mansinho, A., Alho, I., Costa, L., 2016. Molecular mechanisms of bone
               metastasis: which targets came from the bench to the bedside? Int. J. Mol. Sci. 17 (9), 1415.
            Chen, T., Berenson, J., Vescio, R., Swift, R., Gilchick, A., Goodin, S., et al., 2002.
               ‘Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone
               metastases’. J. Clin. Pharmacol. 42 (11), 1228 1236.
            Chen, Y.-C., Sosnoski, D.M., Mastro, A.M., 2010. Breast cancer metastasis to the bone: mechan-
               isms of bone loss. Breast Cancer Res. BCR 12 (6), 215.
            Christ, L.F., Pedro, D., Oliveira, M.D., Almeida, S.D., Vinga, M., 2018. Modelling bone metas-
               tases using fractional derivatives. J. Appl. Nonlinear Dynam. 7 (1), 81 94.
            Coelho, R.M., Vinga, S., Vale ´rio, D., 2015. CancerSys - Multiscale Modeling for Personalized
               Therapy of Bone Metastasis, Technical Report. Instituto Superior Te ´cnico.
            Coelho, R.M., Lemos, J.M., Alho, I., Vale ´rio, D., Ferreira, A.R., Costa, L., et al., 2016. Dynamic
               modeling of bone metastasis, microenvironment and therapy. Integrating parathyroid hormone
               (PTH) effect, anti-resorptive and anti-cancer therapy. J. Theor. Biol. 391, 1 12.
            Crockett, J.C., Rogers, M.J., Coxon, F.P., Hocking, L.J., Helfrich, M.H., 2011. Bone remodelling
               at a glance. J. Cell Sci. 124, 991 998.
            Dhillon, S., Gill, K., 2006. Basic pharmacokinetics, Clinical Pharmacokinetics, first ed.
               Pharmaceutical Press, Chicago, chapter Chapter 1.
            Gibiansky, L., Sutjandra, L., Doshi, S., Zheng, J., Sohn, W., Peterson, M., et al., 2012.
               Population pharmacokinetic analysis of denosumab in patients with bone metastases from
               solid tumors. Clin. Pharmacokinet. 51 (4), 247 260.
            Holen, I., 2012. Pathophysiology of bone metastases. In: Coleman, R., Abrahamsson, P.-A.,
               Hadji, P. (Eds.), Handbook of Cancer-Related Bone Disease, second ed. BioScientifica,
               Sheffield, p. 49.
   39   40   41   42   43   44   45   46   47   48   49